BriaCell Therapeutics (STU:8BT) Pre-Tax Income : €-11.41 Mil (TTM As of Jan. 2024)

BriaCell Therapeutics Pre-Tax Income Chart

BriaCell Therapeutics Annual Data
	Trend	Jul14	Jul15	Jul16	Jul17	Jul18	Jul19	Jul20	Jul21	Jul22	Jul23
Pre-Tax Income		Get a 7-Day Free Trial					-4.20	-3.50	-11.69	-26.38	-18.35

BriaCell Therapeutics Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Pre-Tax Income	Get a 7-Day Free Trial															-11.03	-4.46	-2.19	5.64	-10.41

Competitive Comparison of BriaCell Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, BriaCell Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BriaCell Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BriaCell Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where BriaCell Therapeutics's Pre-Tax Income falls into.

BriaCell Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

BriaCell Therapeutics's Pretax Income for the fiscal year that ended in Jul. 2023 is calculated as

BriaCell Therapeutics's Pretax Income for the quarter that ended in Jan. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-11.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BriaCell Therapeutics  (STU:8BT) Pre-Tax Income Explanation

BriaCell Therapeutics's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BriaCell Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

BriaCell Therapeutics (STU:8BT) Business Description